Trade-Ideas LLC identified

Vascular Solutions

(

VASC

) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Vascular Solutions as such a stock due to the following factors:

  • VASC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $3.1 million.
  • VASC has traded 54,804 shares today.
  • VASC is trading at 9.03 times the normal volume for the stock at this time of day.
  • VASC is trading at a new low 5.60% below yesterday's close.

'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VASC with the Ticky from Trade-Ideas. See the FREE profile for VASC NOW at Trade-Ideas

More details on VASC:

TheStreet Recommends

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. VASC has a PE ratio of 41. Currently there are 3 analysts that rate Vascular Solutions a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Vascular Solutions has been 95,000 shares per day over the past 30 days. Vascular has a market cap of $505.2 million and is part of the health care sector and health services industry. The stock has a beta of 0.74 and a short float of 3.3% with 4.72 days to cover. Shares are down 16.4% year-to-date as of the close of trading on Thursday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Vascular Solutions as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • VASCULAR SOLUTIONS INC has improved earnings per share by 6.7% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. During the past fiscal year, VASCULAR SOLUTIONS INC increased its bottom line by earning $0.72 versus $0.66 in the prior year. This year, the market expects an improvement in earnings ($1.04 versus $0.72).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 15.6% when compared to the same quarter one year prior, going from $2.57 million to $2.97 million.
  • VASC's revenue growth trails the industry average of 29.4%. Since the same quarter one year prior, revenues rose by 15.7%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • VASC has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.36, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for VASCULAR SOLUTIONS INC is rather high; currently it is at 69.13%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 8.04% is above that of the industry average.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.